Trials / Completed
CompletedNCT04712500
A Food-Effect Study of AND017 in Healthy Participants
A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period Crossover Study in Healthy Non-Elderly Chinese Subjects to Evaluate the Food Effect on the Pharmacokinetics of AND017 Following Oral Single-Dose Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Kind Pharmaceuticals LLC · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this phase I study is to evaluate the food effect on the PKs of AND017 following oral single-dose administration in healthy non-elderly Chinese subjects.
Detailed description
This is a single-center, randomized, open-label, two-sequence, two-period crossover study in healthy non-elderly Chinese subjects to evaluate the food effect on the pharmacokinetics, as well as PD and safety of AND017 following oral single-dose administration
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AND017 | AND017 oral capsule |
Timeline
- Start date
- 2020-07-30
- Primary completion
- 2020-08-16
- Completion
- 2020-08-21
- First posted
- 2021-01-15
- Last updated
- 2021-05-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04712500. Inclusion in this directory is not an endorsement.